Re: Role of Telomeres and Telomerase in Cancer

The most important difference between cancer and normall cells is the ability to continuous proliferation. This activation works due to telomeres and telomerase enzyme. Fifty years ago, Leonard Hayflick discovered that cultured normal humans cells have a limited capacity to divide. Today, this with...

Full description

Bibliographic Details
Main Authors: Shay JW, Wright WE
Format: Article
Language:English
Published: Galenos Yayinevi 2016-03-01
Series:Journal of Urological Surgery
Online Access:http://jurolsurgery.org/article_10390/Re-Cell-Adhesion-Molecules-And-Their-Relation-To-cancer-Cell-Stemness
_version_ 1797905848568119296
author Shay JW
Wright WE
author_facet Shay JW
Wright WE
author_sort Shay JW
collection DOAJ
description The most important difference between cancer and normall cells is the ability to continuous proliferation. This activation works due to telomeres and telomerase enzyme. Fifty years ago, Leonard Hayflick discovered that cultured normal humans cells have a limited capacity to divide. Today, this withdrawal from the cell cycle after a certain number of cellular divisions (replicative senescence) is known to be triggered as a result of shortened telomeres. Studies on telomeres and telomerase have begun to provide additional information about aging and cancer development and have created new opportunities in the field of regenerative medicine for telomeropathies. Progressive telomere shortening from cell division (replicative aging) provides a barrier for tumor progression. Continuous cell growth in malignancy correlates with the reactivation of telomerase. Telomerase is a cellular reverse transcriptase that adds new deoxyribonucleic acid (DNA) onto the telomeres that are located at the ends of chromosomes. Telomeres consist of many kilobases of TTAGGG nucleotide repeats. The telomeric nucleotide repeats shorten with each cell division due to replication problems (DNA repair) and oxidative damage. Quiescent/senescent state of the cell bypass can be accomplished by abrogating cell cycle checkpoint genes (such as TP53, p16INK4a, pRb). Telomerase is detected in approximately 90% of all malignant tumors. This telomerase activation has emerged as a target for cancer treatment. Telomerase therapeutics are classified as gene therapy (hTERT-telomerase catalytic protein component, hTR-telomerase functional), immunotherapy (Imetalstat-telomerase template antagonist), and small molecule inhibitors. In the near future, more specific researches on telomers and telomerase will contribute to aging/immortality studies (as stem cells) and to discover new biomarkers for malignant tissue or anticancer therapeutics.
first_indexed 2024-04-10T10:11:39Z
format Article
id doaj.art-cb30ab2c6cfd4964b5a7e2b235476024
institution Directory Open Access Journal
issn 2148-9580
language English
last_indexed 2024-04-10T10:11:39Z
publishDate 2016-03-01
publisher Galenos Yayinevi
record_format Article
series Journal of Urological Surgery
spelling doaj.art-cb30ab2c6cfd4964b5a7e2b2354760242023-02-15T16:22:06ZengGalenos YayineviJournal of Urological Surgery2148-95802016-03-0131292910.4274/jus.2016.01.003Re: Role of Telomeres and Telomerase in CancerShay JW0Wright WE1University of Texas Southwestern Medical Center, Department of Cell Biology, Dallas, USAUniversity of Texas Southwestern Medical Center, Department of Cell Biology, Dallas, USAThe most important difference between cancer and normall cells is the ability to continuous proliferation. This activation works due to telomeres and telomerase enzyme. Fifty years ago, Leonard Hayflick discovered that cultured normal humans cells have a limited capacity to divide. Today, this withdrawal from the cell cycle after a certain number of cellular divisions (replicative senescence) is known to be triggered as a result of shortened telomeres. Studies on telomeres and telomerase have begun to provide additional information about aging and cancer development and have created new opportunities in the field of regenerative medicine for telomeropathies. Progressive telomere shortening from cell division (replicative aging) provides a barrier for tumor progression. Continuous cell growth in malignancy correlates with the reactivation of telomerase. Telomerase is a cellular reverse transcriptase that adds new deoxyribonucleic acid (DNA) onto the telomeres that are located at the ends of chromosomes. Telomeres consist of many kilobases of TTAGGG nucleotide repeats. The telomeric nucleotide repeats shorten with each cell division due to replication problems (DNA repair) and oxidative damage. Quiescent/senescent state of the cell bypass can be accomplished by abrogating cell cycle checkpoint genes (such as TP53, p16INK4a, pRb). Telomerase is detected in approximately 90% of all malignant tumors. This telomerase activation has emerged as a target for cancer treatment. Telomerase therapeutics are classified as gene therapy (hTERT-telomerase catalytic protein component, hTR-telomerase functional), immunotherapy (Imetalstat-telomerase template antagonist), and small molecule inhibitors. In the near future, more specific researches on telomers and telomerase will contribute to aging/immortality studies (as stem cells) and to discover new biomarkers for malignant tissue or anticancer therapeutics.http://jurolsurgery.org/article_10390/Re-Cell-Adhesion-Molecules-And-Their-Relation-To-cancer-Cell-Stemness
spellingShingle Shay JW
Wright WE
Re: Role of Telomeres and Telomerase in Cancer
Journal of Urological Surgery
title Re: Role of Telomeres and Telomerase in Cancer
title_full Re: Role of Telomeres and Telomerase in Cancer
title_fullStr Re: Role of Telomeres and Telomerase in Cancer
title_full_unstemmed Re: Role of Telomeres and Telomerase in Cancer
title_short Re: Role of Telomeres and Telomerase in Cancer
title_sort re role of telomeres and telomerase in cancer
url http://jurolsurgery.org/article_10390/Re-Cell-Adhesion-Molecules-And-Their-Relation-To-cancer-Cell-Stemness
work_keys_str_mv AT shayjw reroleoftelomeresandtelomeraseincancer
AT wrightwe reroleoftelomeresandtelomeraseincancer